Clinical Trial Update: Study of Proteus Syndrome and Related Congenital Disorders

View source ↗

Summary

Clinical trial update noting that the study examining Proteus syndrome and PIK3CA-related overgrowth spectrum is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pik3ca-related Overgrowth Spectrum
• Proteus Syndrome

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Proteus Syndrome, PIK3CA Related Overgrowth Spectrum | Status: RECRUITING